News

First Collagen Hybridizing Peptide Application for Collagen Damage to Nervous Tissue: CHPs Help Confirm Distinct Patterns of Structural Damage in Epineuroclasis and Endoneuroclasis.

Peripheral Nerve Injuries (PNIs) represent a significant clinical challenge, frequently resulting in disability and chronic pain, particularly in younger patients. Recovery following PNI is oftentimes unpredictable and the decision to pursue surgical intervention is complicated by a limited ability to accurately assess the severity and extent of tissue damage. The current PNI classification system,...
View Details

Localization of Therapeutic Fab-CHP Conjugates to Sites of Denatured Collagen for the Treatment of Rheumatoid Arthritis

In a recently accepted article published in Bioconjugate Chemistry, researchers from the University of Utah used CHPs in an antibody-conjugate to address Rheumatoid Arthritis(RA). In this paper, the authors used the Fab region from infliximab (an anti-TNFα therapy known as Remicade®) and conjugated this with CHPs. Figure Caption.  A) Biodistribution of IR680 labeled bFab-(NIRF)CHP...
View Details

Effective enzymatic debridement of burn wounds depends on the denaturation status of collagen

Another great paper using CHPs! A recent article published in Wound Repair and Regeneration evaluated how the level of collagen denaturation within burned tissues influences the effectiveness of enzymatic debridement (removal of damaged tissue). They showed that low-temperature burns (<65 °C) had inadequate debridement, while high-temperature burns (>65 °C) had very effective debridement. By...
View Details